|
|
61 - 80 of 601 <<previous | next>>
| New AIDS Tech Transfers Reinforce Roche Commitment To Strengthen African Manufacturing |
Roche has announced the agreement of two new technology transfers with local manufacturing companies in Africa -- Addis Pharmaceutical Factory in Ethiopia and Varichem Pharmaceuticals in Zimbabwe. As part of Roche's Technology Transfer Initiative, these companies will be provided free of charge with the technical expertise and guidance to manufacture generic HIV medicine, based upon the processes to produce saquinavir, Roche's 2nd line[1] HIV medicine.
2007-06-03 08:00 |
| Researchers Find Deadly Prescription Drug Effects Six Years Before FDA |
Northwestern University's Charles Bennett, M.D., is a super sleuth of potentially deadly prescription drug reactions. He leads a national SWAT team of doctors called RADAR (Research on Adverse Drug Events and Reports) based out of Northwestern's Feinberg School of Medicine. They swoop in to investigate early signs of trouble years before the Food and Drug Administration (FDA) takes notice.A new study by Bennett, the A.C.
2007-06-02 17:00 |
| International Pharmaceutical Federation Supports WHO Action To Promote Smoke-Free Environments |
Today the World Health Organization is urging all across the globe to recognize and participate in World No Tobacco Day, held annually on May 31. This year the event will centre around the theme SMOKE-FREE ENVIRONMENTS, with WHO and associated stakeholders promoting this method as the ONLY effective measure to protect individuals - including women, children, and those sharing a public or workspace â¬" from exposure to and risk of second-hand smoke.
2007-06-02 03:00 |
| AMA To Partner With Sermo To Allow Members To Share Information |
The American Medical Association on Wednesday plans to announce an agreement to partner with Sermo, a startup company that encourages physicians to share information on a Web site and charges investment companies to view the information, which "could serve as tip-offs to drug side effects and other market-moving medical trends,"
2007-06-01 16:00 |
| Release Of New Capsule Endoscopes Will Spur Market Growth |
Millennium Research Group (MRG) has conducted a detailed analysis of the US video and high-tech device market in its US Markets for Video and High-Tech Hardware Devices 2007 report. The analysis reveals that capsule endoscopy is the fastest-growing segment of the market, with a compound annual growth rate set to reach approximately 50% over the next five years.
2007-05-31 03:00 |
| FDA Requests Boxed Warning For Contrast Agents Used To Improve MRI Images |
The U.S. Food and Drug Administration (FDA) has asked manufacturers to include a new boxed warning on the product labeling of all gadolinium-based contrast agents which are used to enhance the quality of magnetic resonance imaging (MRI). The requested warning would state that patients with severe kidney insufficiency who receive gadolinium-based agents are at risk for developing a debilitating, and a potentially fatal disease known as nephrogenic systemic fibrosis (NSF).
2007-05-30 14:00 |
| FDA Approves Contraceptive For Continuous Use |
The Food and Drug Administration (FDA) today approved Lybrel, the first continuous use drug product for prevention of pregnancy. The new contraceptive, Lybrel, comes in a 28 day-pill pack with low-dose combination tablets that contain 90 micrograms of a progestin, levonorgestrel, and 20 micrograms of an estrogen, ethinyl estradiol, which are active ingredients available in other approved oral contraceptives.
2007-05-30 14:00 |
| PBS Cost Recovery Will Compromise PBAC Independence And Increase Costs To Patients, Australia |
AMA (Australian Medical Association) President, Dr Mukesh Haikerwal, today warned that the Government's Pharmaceutical Benefits Scheme (PBS) cost recovery plan will undermine the independence of the Pharmaceutical Benefits Advisory Committee (PBAC) and provide the pharmaceutical industry with another line of attack against PBAC decisions. Dr Haikerwal said the new policy has effectively re-defined PBAC's work as a service to the private sector.
2007-05-30 14:00 |
| Tuning Nanostructures For New Drug Delivery Systems |
In the paper Tuning Curvature and Stability of Monoolein Bilayers by Designer Lipid-Like Peptide Surfactants, new strategies for the encapsulation and the delivery of biological active materials are shown up. In particular, A. Yaghmur, M. Rappolt, and P. Laggner (Institute of Biophysics and Nanosystems Research (IBN), Austrian Academy of Sciences), in collaboration with S.
2007-05-30 14:00 |
61 - 80 of 601 <<previous | next>>
|
|
|
